awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40940984-741221F2-ECC3-41CC-B66A-B8FC52F71A9F
Q40940984-741221F2-ECC3-41CC-B66A-B8FC52F71A9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40940984-741221F2-ECC3-41CC-B66A-B8FC52F71A9F
Developments in the field of allergy in 2014 through the eyes of Clinical and Experimental Allergy.
P2860
Q40940984-741221F2-ECC3-41CC-B66A-B8FC52F71A9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40940984-741221F2-ECC3-41CC-B66A-B8FC52F71A9F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ff4bb3cd14d4ce367e291a1339a31144bfa7bbd5
P2860
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.